12086555

Source:http://linkedlifedata.com/resource/pubmed/id/12086555

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0245109
pubmed:issue	7-8
pubmed:dateCreated	2002-6-27
pubmed:abstractText	To summarize the safety data arising from clinical trials of anakinra, a human recombinant form of interleukin-1 receptor antagonist (IL-1Ra) developed for the treatment of rheumatoid arthritis (RA).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9203131
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/IL1RN protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist..., http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1, http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins
pubmed:status	MEDLINE
pubmed:issn	1060-0280
pubmed:author	pubmed-author:CalabreseLeonard HLH
pubmed:issnType	Print
pubmed:volume	36
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1204-9
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12086555-Antirheumatic Agents, pubmed-meshheading:12086555-Arthritis, Rheumatoid, pubmed-meshheading:12086555-Drug Therapy, Combination, pubmed-meshheading:12086555-Half-Life, pubmed-meshheading:12086555-Humans, pubmed-meshheading:12086555-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:12086555-Methotrexate, pubmed-meshheading:12086555-Randomized Controlled Trials as Topic, pubmed-meshheading:12086555-Receptors, Interleukin-1, pubmed-meshheading:12086555-Sialoglycoproteins
pubmed:articleTitle	Anakinra treatment of patients with rheumatoid arthritis.
pubmed:affiliation	Department of Rheumatic & Immunologic Diseases, Cleveland, OH, USA. calabri@cesmtp.ccf.org
pubmed:publicationType	Journal Article, Review